 |
市場調查報告書
商品編碼
1741168
電轉化細胞市場，按應用、細胞類型、轉化效率、包裝形式、最終用戶和地區分類Electrocompetent Cells Market, By Application, By Cell Type, By Transformation Efficiency, By Packaging Format, By End User, By Geography |
||||||
價格
簡介目錄
預計 2025 年電轉化細胞市場規模為 25.3 億美元，到 2032 年將達到 50.9 億美元，2025 年至 2032 年的年複合成長率為 10.5%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年的市場規模 | 25.3億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025-2032年年複合成長率： | 10.50% | 2032年價值預測 | 50.9億美元 |
電穿孔感受態細胞是透過電穿孔技術製備的可吸收DNA的細菌細胞。電穿孔技術將細胞暴露於電場中，在細胞膜上產生暫時的孔洞。這使得外來DNA能夠進入細胞並整合到細胞自身的DNA中。電穿孔感受態細胞具有廣泛的應用，特別是在生物技術和基因工程領域。外來DNA插入細胞後，在細胞內複製，產生插入DNA的多個拷貝。這些拷貝可用於生產蛋白質。電穿孔感受態細胞也用於基因工程，以創造基因改造生物。在農業領域，它可以用於培育具有所需性狀的作物，在醫學領域，它可以用於培育能夠產生治療性蛋白質的細菌。
市場動態：
分子克隆研究領域的研究和資金投入日益增加，預計將推動對感受態細胞的需求，因為它們在各種生物技術程序中都具有極高的效率。這些因素預計將在預測期內支撐全球電感受態細胞市場的成長。
然而，對具有紮實技術知識的熟練專業人員的需求是預測期內阻礙全球電轉化細胞市場成長的主要因素之一。
本研究的主要特點
- 本研究報告對全球電轉化細胞市場進行了詳細分析，並提供了預測期 2025-2032（以 2024 年為基準年）的市場規模和年複合成長率（CAGR%）。
- 它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
- 全球電轉化細胞市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
- 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
- 相關人員將透過用於分析全球電轉化細胞市場的各種策略矩陣來做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 分子克隆研究的研究和資助活動增加
- 增加基因治療的投資
- 限制因素
- 專業技能人才短缺
- 機會
- 重組DNA技術的進展
- 影響分析
- 主要亮點
- 監管情景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購場景
4. 電轉化細胞市場-冠狀病毒（COVID-19）大流行的影響
- COVID-19流行病學
- 供需側分析
- 經濟影響
5. 電轉化細胞市場（依應用分類），2020 年至 2032 年
- 複製
- 蛋白質表現
- 誘變
- 基因組DNA文庫構建
- 抗體產生
- 高通量篩檢
- 其他
6. 電轉化細胞市場（依細胞類型），2020-2032
- 大腸桿菌（E. coli）
- 釀酒酵母（S. cerevisiae）
- 枯草桿菌（B. subtilis）
- 惡臭假單胞菌（P. putida）
- 肺炎鏈球菌
- 其他
7. 2020 年至 2032 年電轉化細胞市場（依轉化效率）
- 高效率電池
- 超高效率電池
8. 2020 年至 2032 年以包裝形式分類的電轉化細胞市場
- 管子
- 盤子
- 自訂格式
9. 2020 年至 2032 年電轉化細胞市場（依最終用戶分類）
- 製藥和生物技術公司
- 學術研究所
- 合約研究組織（CRO）
- 其他
10. 2020-2032 年電轉化細胞市場（按地區）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 非洲
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 南非
- 北非
- 中部非洲
第11章競爭格局
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- QIAGEN NV
- New England Biolabs, Inc.
- GenScript Biotech Corporation
- Lucigen Corporation
- Takara Bio Inc.
- Delphi Genetics SA
- IBA GmbH
- Scarab Genomics LLC
- Zymo Research Corporation
- Bioline GmbH（Meridian Bioscience）
- SelectScience
- Biosearch Technology
第12章 章節
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI5897
Electrocompetent Cells Market is estimated to be valued at USD 2.53 Bn in 2025 and is expected to reach USD 5.09 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2.53 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 10.50% | 2032 Value Projection: | USD 5.09 Bn |
Electrocompetent cells are bacterial cells that have been prepared for the uptake of DNA through electroporation, a process that involves exposing the cells to an electric field that creates temporary pores in the cell membranes. This allows foreign DNA to enter the cell, which can then be incorporated into the cell's own DNA. This technique is commonly used in molecular biology for cloning purposes, and the cells are often used in research and development in the biotechnology and pharmaceutical industries. electrocompetent cells have a wide range of applications, particularly in the field of biotechnology and genetic engineering. here are some of the key applications,.such as cloning, electrocompetent cells are often used in cloning experiments. The foreign DNA is inserted into the cells, which then replicate, producing many copies of the inserted DNA. They are used in the production of proteins. Moreover, electrocompetent cells are used in genetic engineering to create genetically modified organisms. This can be used in agriculture to create crops with desirable traits, or in medicine to create bacteria that produce therapeutic proteins.
Market Dynamics:
There is a rise in research activities and funding activities in molecular cloning studies. This in turn is expected to boost the demand for competent cells, as they are highly efficacious in various biotechnology procedures. This factor is expected to support the growth of the global electrocompetent cells market over the forecast period.
However, the need for skilled professionals with sound technical knowledge is one of the major factors expected to hamper growth of the global electrocompetent cells market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global electrocompetent cells market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global electrocompetent cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), SelectScience and Biosearch Technology.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global electrocompetent cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electrocompetent cells market
Global Electrocompetent Cells Market Detailed Segmentation:
- By Application:
- Cloning
- Protein Expression
- Mutagenesis
- Genomic DNA Library Construction
- Antibody Production
- High-Throughput Screening
- Others
- By Cell Type
- Escherichia coli (E. coli)
- Saccharomyces cerevisiae (S. cerevisiae)
- Bacillus subtilis (B. subtilis)
- Pseudomonas putida (P. putida)
- Streptococcus pneumoniae (S. pneumoniae)
- Others
- By Transformation Efficiency:
- High Efficiency Cells
- Ultra-High Efficiency Cells
- By Packaging Format:
- Tubes
- Plates
- Custom Formats
- By End User:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- QIAGEN N.V.
- New England Biolabs, Inc.
- GenScript Biotech Corporation
- Lucigen Corporation
- Takara Bio Inc.
- Delphi Genetics S.A.
- IBA GmbH
- Scarab Genomics LLC
- Zymo Research Corporation
- Bioline GmbH (Meridian Bioscience)
- SelectScience
- Biosearch Technology
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Electrocompetent Cells, By Application
- Market Electrocompetent Cells, By Cell Type
- Market Electrocompetent Cells, By Transformation Efficiency
- Market Electrocompetent Cells, By Packaging Format
- Market Electrocompetent Cells, By End User
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rise in research activities and funding activities in molecular cloning studies
- Increasing investments in gene therapy
- Restraints
- Lack of skilled professionals
- Opportunities
- Advancements in recombinant DNA technology
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Electrocompetent Cells Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Electrocompetent Cells Market , By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Cloning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Protein Expression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Mutagenesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Genomic DNA Library Construction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Antibody Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- High-Throughput Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Electrocompetent Cells Market, By Cell Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Escherichia coli (E. coli)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Saccharomyces cerevisiae (S. cerevisiae)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Bacillus subtilis (B. subtilis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Pseudomonas putida (P. putida)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Streptococcus pneumoniae (S. pneumoniae)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Electrocompetent Cells Market, By Transformation Efficiency, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- High Efficiency Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Ultra-High Efficiency Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Electrocompetent Cells Market, By Packaging Format, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Tubes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Plates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Custom Formats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Electrocompetent Cells Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
10. Electrocompetent Cells Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- New England Biolabs, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GenScript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lucigen Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Delphi Genetics S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- IBA GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Scarab Genomics LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Zymo Research Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bioline GmbH (Meridian Bioscience)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SelectScience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biosearch Technology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
